Gene and cell therapy for prion diseases.

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Prion diseases are fatal neurodegenerative disorders caused by abnormal prion protein (PrPSc) accumulation.
• Currently, no effective treatments exist for prion diseases.
• Early diagnosis is challenging, limiting therapeutic windows.

Purpose of the Study:

• To review potential therapeutic strategies for prion diseases.
• To highlight targets for interfering with PrPSc propagation and mitigating brain damage.
• To explore gene and cell-based therapies, including stem cell transplantation.

Main Methods:

• Review of existing literature on prion disease therapeutics.
• Analysis of RNA interference, immunization, and dominant-negative inhibition approaches.
• Evaluation of gene therapy, cell therapy, and combined cell-gene therapy strategies.

Main Results:

• Various molecular approaches show promise in blocking PrPSc production.
• Gene therapy offers an alternative delivery system for anti-prion molecules.
• Combined cell and gene therapy, alongside stem cell transplantation, presents a promising dual approach.

Conclusions:

• Targeting PrPSc formation and addressing existing brain damage are crucial for effective prion disease treatment.
• Gene and cell replacement therapies, particularly when combined, offer significant potential.
• Stem cell transplantation represents a viable strategy for prion disease management.